| Name | Title | Contact Details |
|---|
Nextech`s specialty-focused technology solutions are personalized to meet the unique workflow requirements of specialty providers, helping practices increase efficiencies across their clinical, administrative, financial and marketing functions using a single platform. Offering all-in-one, ONC-certified electronic medical records (EMR/EHR), practice management, revenue management, and patient engagement software and services, Nextech is recognized as the top single solution provider for ophthalmology, plastic surgery and dermatology, serving a client base of more than 9,000 providers and 45,000 office staff members. Offering physicians intelligent healthcare technology, Nextech focuses on the success of its specialty practices through consultative guidance and implementation of solutions tailored to the speed and workflows of individual providers. Having recently acquired MDIntelleSys, the leading cloud-based EHR for eye care, Nextech continues to drive product innovation and deeper engagement with its customers, offering both cloud-based and client-server offerings to meet each practices` unique preferences.
For 25 years we have earned a reputation for building technology solutions that solve the most complex business problems in supply chain, inventory and now omni-channel.
softelcom is a Fairview, NJ-based company in the Software and Internet sector.
TMA Solutions was established in 1997 to provide offshore software development services to leading companies worldwide. Our talent team was selected from the large pool of Vietnam IT resources and their ability has been proven from many successful
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.